114027
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
维生素 K2 通过激活 NRF2/FSP1 通路抑制成骨细胞铁死亡从而预防糖皮质激素诱导的骨质疏松症
Authors Zhang Z, Rong X, Ren Q, Kou Y , Guo J , Li M
Received 11 August 2025
Accepted for publication 17 December 2025
Published 23 December 2025 Volume 2025:19 Pages 11525—11545
DOI https://doi.org/10.2147/DDDT.S554610
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Yan Zhu
Zhichao Zhang,1– 4 Xing Rong,1,3 Qinghua Ren,1,3 Yuying Kou,5 Jie Guo,1– 3 Minqi Li1,3
1Department of Bone Metabolism, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, Shandong, People’s Republic of China; 2Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 3Center of Osteoporosis and Bone Mineral Research, Shandong University, Jinan, Shandong, People’s Republic of China; 4Department of Stomatology, The Second Hospital of Shandong University, Jinan, Shandong, People’s Republic of China; 5School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
Correspondence: Jie Guo, Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, No. 44-1 Wenhua Road West, Jinan, Shandong, 250012, People’s Republic of China, Fax +8653188382923, Email kqgj@sdu.edu.cn Yuying Kou, School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, No. 6699 Qingdao Road, Jinan, Shandong, 250117, People’s Republic of China, Fax +8653159556822, Email 1453870058@qq.com
Purpose: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, and its pathogenesis is closely associated with oxidative stress and impaired osteogenic differentiation. Vitamin K2 (VK2) has strong antioxidant properties and potent bone-forming effects, but its application in GIOP is still unclear. This study investigates the therapeutic potential of VK2 in GIOP and elucidates its underlying molecular mechanisms.
Methods: Dexamethasone (DEX) was used to establish GIOP model within C57BL/6 mice. The bone mass was assessed using micro-computed tomography (micro-CT), hematoxylin and eosin (HE) staining, and Masson’s trichrome staining in vivo. The osteoblast activity and the expression of osteogenic and ferroptosis-related markers were evaluated via immunohistochemistry (IHC), RT-qPCR, Western blotting, ALP and alizarin red staining. The mitochondrial function and lipid peroxidation of MC3T3-E1 cells were detected by flow cytometry, immunofluorescence and specific kits.
Results: VK2 partially prevented bone mass reduction and osteoblast activity inhibition in GIOP mice. VK2 not only reversed the DEX-induced reductions in Tb.N, BV/TV, and Tb.Th, but also significantly increased the expression of osteogenic markers, including OCN and ALP (P< 0.05). Moreover, VK2 improved DEX-induced ferroptosis, oxidative stress and mitochondrial dysfunction in MC3T3-E1 cells and promoted osteogenic differentiation in vitro, which could be reversed by ferroptosis inducer (P< 0.05). VK2 also increased the expression of NRF2, HO-1 and FSP1 which inhibited by DEX in vivo and in vitro (P< 0.05). The inhibition of FSP1 and NRF2 reversed the osteogenic differentiation promotion and ferroptosis inhibition by VK2 (P< 0.05).
Conclusion: VK2 restores mitochondrial function and reduces lipid peroxidation and ferroptosis via the NRF2/FSP1 signaling pathway, thereby facilitating osteoblast differentiation and improving bone mass in GIOP mice. This finding not only provides a fresh perspective on the etiology of GIOP but also positions ferroptosis inhibition as a promising and innovative therapeutic strategy for this condition, with VK2 emerging as a potential candidate for clinical translation.
Keywords: GIOP, VK2, osteoblast, ferroptosis, NRF2, FSP1
1Department of Bone Metabolism, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, Shandong, People’s Republic of China; 2Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 3Center of Osteoporosis and Bone Mineral Research, Shandong University, Jinan, Shandong, People’s Republic of China; 4Department of Stomatology, The Second Hospital of Shandong University, Jinan, Shandong, People’s Republic of China; 5School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
Correspondence: Jie Guo, Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, No. 44-1 Wenhua Road West, Jinan, Shandong, 250012, People’s Republic of China, Fax +8653188382923, Email kqgj@sdu.edu.cn Yuying Kou, School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, No. 6699 Qingdao Road, Jinan, Shandong, 250117, People’s Republic of China, Fax +8653159556822, Email 1453870058@qq.com
Purpose: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, and its pathogenesis is closely associated with oxidative stress and impaired osteogenic differentiation. Vitamin K2 (VK2) has strong antioxidant properties and potent bone-forming effects, but its application in GIOP is still unclear. This study investigates the therapeutic potential of VK2 in GIOP and elucidates its underlying molecular mechanisms.
Methods: Dexamethasone (DEX) was used to establish GIOP model within C57BL/6 mice. The bone mass was assessed using micro-computed tomography (micro-CT), hematoxylin and eosin (HE) staining, and Masson’s trichrome staining in vivo. The osteoblast activity and the expression of osteogenic and ferroptosis-related markers were evaluated via immunohistochemistry (IHC), RT-qPCR, Western blotting, ALP and alizarin red staining. The mitochondrial function and lipid peroxidation of MC3T3-E1 cells were detected by flow cytometry, immunofluorescence and specific kits.
Results: VK2 partially prevented bone mass reduction and osteoblast activity inhibition in GIOP mice. VK2 not only reversed the DEX-induced reductions in Tb.N, BV/TV, and Tb.Th, but also significantly increased the expression of osteogenic markers, including OCN and ALP (P< 0.05). Moreover, VK2 improved DEX-induced ferroptosis, oxidative stress and mitochondrial dysfunction in MC3T3-E1 cells and promoted osteogenic differentiation in vitro, which could be reversed by ferroptosis inducer (P< 0.05). VK2 also increased the expression of NRF2, HO-1 and FSP1 which inhibited by DEX in vivo and in vitro (P< 0.05). The inhibition of FSP1 and NRF2 reversed the osteogenic differentiation promotion and ferroptosis inhibition by VK2 (P< 0.05).
Conclusion: VK2 restores mitochondrial function and reduces lipid peroxidation and ferroptosis via the NRF2/FSP1 signaling pathway, thereby facilitating osteoblast differentiation and improving bone mass in GIOP mice. This finding not only provides a fresh perspective on the etiology of GIOP but also positions ferroptosis inhibition as a promising and innovative therapeutic strategy for this condition, with VK2 emerging as a potential candidate for clinical translation.
Keywords: GIOP, VK2, osteoblast, ferroptosis, NRF2, FSP1